Point72 Hong Kong LTD Royalty Pharma PLC Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $2.41 Million - $2.75 Million	-87,836 Reduced 76.63%	26,789 $813,000
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $3 Million - $3.35 Million	114,625 New	114,625 $3.22 Million
Q1 2022 May 16, 2022	SELL	$37.46 - $42.44 $242,740 - $275,011	-6,480 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $227,901 - $275,270	6,480 New	6,480 $258,000
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $194,324 - $227,124	-5,377 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $214,273 - $250,729	5,377 New	5,377 $220,000
Q3 2020 Nov 16, 2020	SELL	$38.56 - $48.36 $1.45 Million - $1.82 Million	-37,659 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $1.68 Million - $1.96 Million	37,659 New	37,659 $1.83 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.